Diaphragm Function After Reversal of Rocuronium-induced Neuromuscular Blockade With Sugammadex or Neostigmine in Children

Exclusion Criteria

• •Patients with a history of severe respiratory disease with a high risk of bronchoconstriction
• •Patients with abnormal findings on preoperative chest radiography such as severe atelectasis, pneumothorax, pleural effusion, or pneumonia.
• •Patients with severe renal or liver disease, or neuromuscular disease
• •Patients with a history of allergy to drugs (sugammadex, rocuronium neostigmine)
• •Patients with significant bradycardia
• •Patients scheduled for surgery where estimated blood loss during surgery is expected to be more than 30% of estimated blood volume, or cases where fluid imbalance is expected to be severe during surgery
• •patients scheduled for lung parenchyme/diaphragm/thoracic surgery
• •other researchers considered it inappropriate to participate in research.